PGNY250117C20000
- 0.80
- +0.15+23.08%
Progyny Newsroom
Fund Update: RIVERBRIDGE PARTNERS LLC Just Disclosed New Holdings
Progyny Strengthens Leadership With New Director Appointment
Press Release: Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors
Progyny, Inc.'s (NASDAQ:PGNY) Stock Is Going Strong: Is the Market Following Fundamentals?
Truist Financial Maintains Progyny(PGNY.US) With Hold Rating
Progyny (PGNY) Gets a Hold From Truist Financial
Leerink Partners Maintains Progyny(PGNY.US) With Hold Rating, Cuts Target Price to $20
BofA Securities Maintains Progyny(PGNY.US) With Buy Rating, Maintains Target Price $21
Progyny's Premarket Value Rises 5.8% on Improved 4Q Forecast
Express News | Progyny Inc : Leerink Partners Raises Target Price to $20 From $17
Progyny Sees Q4 Results Slightly Above Guidance Ranges Provided in November
Express News | Progyny : Now Expect Q4 Revenue, Net Income and Adj Ebitda Slightly Above Ranges Provided in Nov
Express News | Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services
Express News | Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference
Progyny Pick of the Week at Smart Insider Following CEO, Executive Chair Stock Purchases
Progyny CEO & Director Acquires 136% More Stock
Insider Spends US$3.0m Buying More Shares In Progyny
Progyny Up Over 11%, on Pace for Largest Percent Increase Since February 2023 -- Data Talk
Progyny, Inc. (PGNY): A Bull Case Theory
Executive Chairman David Schlanger Buy 150K Shares of Progyny Common Stock